| Date Filed | Type | Description |
| 04/23/2019 |
4
| Hager Alicia J. (SVP and General Counsel) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 39,488 shares
@ $0 |
|
| 04/23/2019 |
4
| ROOT JONATHAN D (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 121,020 shares
@ $0 |
|
| 04/23/2019 |
4
| LASERSOHN JACK W (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 185,709 shares
@ $0
Unknown transaction of 1,119,905 shares
@ $0
Unknown transaction of 380,299 shares
@ $0 |
|
| 04/23/2019 |
4
| Lewicki John A. (President and CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 142,534 shares
@ $0 |
|
| 04/23/2019 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 1,991,602 shares
@ $0
Unknown transaction of 18,940 shares
@ $0 |
|
| 04/23/2019 |
4
| Li Yvonne (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 65,895 shares
@ $0 |
|
| 04/23/2019 |
4
| Stagg Robert (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 28,917 shares
@ $0 |
|
| 04/23/2019 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 80,500 shares
@ $0 |
|
| 12/26/2018 |
4
| Gurney Austin (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 11,117 shares
@ $0.5999, valued at
$6.7k
|
|
| 10/11/2018 |
4
| Stagg Robert (SVP, Clinical R&D) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 927 shares
@ $2.01, valued at
$1.9k
|
|
| 10/11/2018 |
4
| Li Yvonne (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 927 shares
@ $2.02, valued at
$1.9k
|
|
| 10/11/2018 |
4
| Gurney Austin (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,156 shares
@ $2.01, valued at
$2.3k
|
|
| 10/11/2018 |
4
| Hager Alicia J. (SVP & General Counsel) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,156 shares
@ $2.02, valued at
$2.3k
|
|
| 10/11/2018 |
4
| Lewicki John A. (President & CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,156 shares
@ $2.01, valued at
$2.3k
|
|
| 10/10/2018 |
4
| Li Yvonne (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,229 shares
@ $2.1288, valued at
$2.6k
|
|
| 10/10/2018 |
4
| Gurney Austin (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,686 shares
@ $2.1289, valued at
$3.6k
|
|
| 10/10/2018 |
4
| Stagg Robert (SVP, Clinical R&D) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,686 shares
@ $2.1289, valued at
$3.6k
|
|
| 10/10/2018 |
4
| Lewicki John A. (President & CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 2,296 shares
@ $2.1289, valued at
$4.9k
|
|
| 10/10/2018 |
4
| Hager Alicia J. (SVP & General Counsel) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,686 shares
@ $2.1288, valued at
$3.6k
|
|
| 06/25/2018 |
4
| WYZGA MICHAEL S (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/25/2018 |
4
| PAKIANATHAN DEEPIKA (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/25/2018 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/25/2018 |
4
| KARSEN PERRY A (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/25/2018 |
4
| LASERSOHN JACK W (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/25/2018 |
4
| ROOT JONATHAN D (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/25/2018 |
4
| Winningham Rick E (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 04/26/2018 |
4
| Li Yvonne (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 5,062 shares
@ $2.6777, valued at
$13.6k
|
|
| 04/26/2018 |
4
| Stagg Robert (SVP, Clinical R&D) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,051 shares
@ $2.6779, valued at
$10.8k
|
|
| 04/26/2018 |
4
| Lewicki John A. (President & CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,557 shares
@ $2.6777, valued at
$12.2k
|
|
| 04/26/2018 |
4
| Gurney Austin (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,051 shares
@ $2.6778, valued at
$10.8k
|
|
| 04/26/2018 |
4
| Hager Alicia J. (SVP & General Counsel) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,051 shares
@ $2.6778, valued at
$10.8k
|
|
| 03/23/2018 |
3
| Stagg Robert (SVP, Clinical R&D) has filed a Form 3 on OncoMed Pharmaceuticals Inc |
| 03/20/2018 |
4
| Li Yvonne (See Remarks) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 75,000 options to buy
@ $2.98, valued at
$223.5k
|
|
| 03/20/2018 |
3
| Li Yvonne (See Remarks) has filed a Form 3 on OncoMed Pharmaceuticals Inc |
|